Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NBTY CFO Kamil Anticipates Rebound In Vitamin Market Around The Corner

This article was originally published in The Tan Sheet

Executive Summary

NBTY will have to cycle through another quarter in order to have a clearer picture of its Rexall and retail businesses with regard to year-over-year comparisons, CFO Harvey Kamil said

You may also be interested in...



GNC To Issue IPO To Capitalize On First Quarter Turnaround, Health Awareness

GNC hopes to raise $345 mil. through an initial public offering of shares, according to a preliminary prospectus filed May 28 with the Securities & Exchange Commission

Consumer Reports Article Highlights “Dangerous” Supplements

The dietary supplement industry faces more negative publicity after a Consumer Reports article dubbed twelve supplements the "dirty dozen" that consumers should avoid

NBTY Aiming To Double Rexall Earnings; Closes Deal

NBTY plans to double newly acquired Rexall Sundown's earnings before interest, taxes, depreciation and amortization (EBITDA) to $78 mil. in the next nine months

Related Content

Topics

UsernamePublicRestriction

Register

PS097174

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel